Companies invest €700,000 in high-tech biomaterial company

High-Tech Gründerfonds and STIFT are jointly investing €700,000 (£563,000) in JeNaCell, a spin-off from the Friedrich Schiller University in Jena, Germany.

The capital will be used to build up automated production in the creation of a high-tech biomaterial.

The biomaterial, which will be made up of natural nanostructures, can reportedly be used to make innovative medical and cosmetic products.

The material is not only suitable for treating poorly healing wounds but also enables promising applications for wellness products.